IMGS-401

N/A

Report date: 2025/02/17 16:02:12

Base Information

Drug NameIMGS-401
Drug Alias NameIMGS-401
ClassificationBiologics
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed death-ligand 2 inhibitorsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsProgrammed death-ligand 1Programmed death-ligand 2Cytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunoGenesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunoGenesis Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A